Athira Pharma, Inc. (ATHA) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 67.4M | 243K | 200K | 243K | 0 | 0 | 242K | 242K | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | -67.4M | -243K | -200K | -243K | 0 | 0 | -242K | -242K | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | 100% | - | - | 17.36% | -0.41% | - | - | - | - | - | - | - |
| Operating Expenses | 18.14M | 11.16M | 6.63M | 7.09M | 9.29M | 15.57M | 29.62M | 27.79M | 27.45M | 29.01M | 35.04M | 31.64M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 6.88M | 3.77M | 4.05M | 3.63M | 5.23M | 6.2M | 7.57M | 5.87M | 6.45M | 6.96M | 7.84M | 10.03M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 11.26M | 6.96M | 2.58M | 3.66M | 4.3M | 9.37M | 17.92M | 21.91M | 20.99M | 23.68M | 27.2M | 21.61M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 443K | 0 | -200K | -243K | 0 | 1000K | 0 | 0 | -1000K | 0 | 0 |
| Operating Income | -17.21M | -78.56M | -6.87M | -7.29M | -9.54M | -15.57M | -29.62M | -28.03M | -27.69M | -29.01M | -35.04M | -31.64M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -80.52% | -404.72% | 76.79% | 73.99% | 65.56% | 46.35% | 15.47% | 11.42% | 7% | 11.88% | -45.2% | -34.24% |
| EBITDA | -17.21M | -79.12M | -6.77M | -7.09M | -9.29M | -15.32M | -29.38M | -27.79M | -27.45M | -28.77M | -34.8M | -31.4M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -85.24% | -416.32% | 76.97% | 74.48% | 66.14% | 46.74% | 15.58% | 11.5% | 7.07% | 11.99% | -45.59% | -34.47% |
| D&A (Non-Cash Add-back) | 0 | -551K | 108K | 200K | 243K | 243K | 243K | 242K | 242K | 245K | 244K | 244K |
| EBIT | 0 | 22.72M | -6.61M | -6.97M | -9.14M | -15.57M | -25.49M | -28.03M | -27.69M | -30.64M | -35.04M | -31.64M |
| Net Interest Income | 0 | -981K | 263K | 325K | 393K | 563K | 880K | 1.17M | 1.35M | -221K | 2.07M | 0 |
| Interest Income | 0 | -981K | 263K | 325K | 393K | 563K | 880K | 1.17M | 1.35M | 1.73M | 2.07M | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.95M | 0 | 0 |
| Other Income/Expense | -15.73M | -4.32M | 263K | 325K | 393K | 563K | 880K | 1.17M | 1.35M | 1.73M | 2.07M | 2.04M |
| Pretax Income | -32.95M | -82.89M | -6.61M | -6.97M | -9.14M | -15M | -28.74M | -26.86M | -26.34M | -27.29M | -32.97M | -29.6M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -32.95M | -82.89M | -6.61M | -6.97M | -9.14M | -15M | -28.74M | -26.86M | -26.34M | -27.29M | -32.97M | -29.6M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -260.36% | -452.48% | 77% | 74.06% | 65.28% | 45.01% | 12.83% | 9.25% | 5.33% | 9.46% | -63.31% | -21.62% |
| Net Income (Continuing) | -32.95M | -82.89M | -6.61M | -6.97M | -9.14M | -15M | -28.74M | -26.86M | -26.34M | -27.29M | -32.97M | -29.6M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.73 | -18.94 | -1.68 | -1.78 | -2.30 | -3.90 | -7.50 | -7.00 | -6.90 | -7.20 | -8.70 | -7.80 |
| EPS Growth % | 24.78% | -385.64% | 77.6% | 74.57% | 66.67% | 45.83% | 13.79% | 10.26% | -1.47% | -5.88% | -102.33% | -20% |
| EPS (Basic) | -1.73 | -18.94 | -1.68 | -1.78 | -2.30 | -3.90 | -7.50 | -7.00 | -6.90 | -7.20 | -8.70 | -7.80 |
| Diluted Shares Outstanding | 19.03M | 4.28M | 3.94M | 3.91M | 3.9M | 3.85M | 3.85M | 3.84M | 3.83M | 3.81M | 3.81M | 3.8M |
| Basic Shares Outstanding | 19.03M | 4.28M | 3.94M | 3.91M | 3.9M | 3.85M | 3.85M | 3.84M | 3.83M | 3.81M | 3.81M | 3.8M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |